Kwok Ho Tam
Analyst · Tian Dan from CICC
Thank you, Mr. Ma, and thank you, Harriet, and hello, everyone. To our Asian participants, thanks so much for joining us on a Friday night.
Just now, Mr. Ma mentioned some key metrics for Q1 as well as our April run rate numbers. I think I would like to first start by providing some more details on these metrics to help set up the context of the line by line discussions of our Q1 results.
For Q1, GWP facilitated on our platform was RMB 597.9 million, which was up 40.6% year-over-year. As you can appreciate, given COVID-19 impact on overall economic activity, which has resulted in disruption to normal business operations in both February and March, Q1 was a very tough quarter for the entire industry in general in terms of new policy distribution.
The pandemic obviously affected the average consumer's willingness to spend money on discretionary items, especially on insurance products like our long-term life and health products, which is our strategic focus for a long time. The fact that we have been able to deliver double-digit growth for GWP in the first quarter is a big testament to our online business model as well as a swift transition to a remote working system for our staff. In addition, given that we have established ourselves as a pure online insurance brokerage platform in our 14 years of history, we are also relatively insulated from the negative impact on productivity as compared to some of our more traditional off-line industry peers.
To further breakdown the GWP figure for Q1, renewal premiums accounted for RMB 321 million, growing by 2.8x from the same period of last year. Renewal premiums accounted for 53.7% of our total GWP in Q1 as compared to 19.7% in the same period of last year. I think 2 key takeaways from these metrics is that, number one, I think we are starting to see more better visibility on the contribution from renewal premium to overall revenue line, which will help to provide a more stable and recurring stream of revenues going forward. And number two, these strong renewal metrics also demonstrate the quality of a long-term life and health insurance customers with high renewal rates, which will further provide our insurer partners with positive reassurance on the quality of our customer acquisition online and further strengthen our dual engine business model of servicing both insurance customers and insurance companies.
In terms of first year premiums, as we have explained before, we saw a negative impact on new policy sales in Q1 due to COVID-19. First year premiums facilitated in Q1 was down by 19.1% year-over-year. However, if you look at -- if we look at our long-term health segment, we're actually able to deliver robust growth, ramping up our first year premiums by 18% quarter-over-quarter in Q1. More importantly, long-term life and health GWP accounted for 93.8% of our total GWP in Q1, which marked the second consecutive quarter for this metric to come in above 90% as we continue to execute on our focus of long-term life and health.
Now turning to our revenue line. Total operating revenue for Q1 was RMB 248.7 million, which was down by 1.1% year-over-year. The slight decline in revenue despite a double-digit growth in overall GWP was primarily attributable to the increased proportion of renewal premiums in the GWP figure, as we explained before, coupled with the decrease in first year premiums facilitated during Q1 as a result of COVID-19. As we receive lower brokerage commission rates for renewal premiums as compared to first year premiums, the combination of these 2 key factors, therefore, resulted in a lower average brokerage commission rate of 41.4% in Q1 as compared to 58.8% in the same period last year. However, if you look at our average brokerage commission rate, it's actually improved quarter-over-quarter from 39.5% in Q4 of 2019 due to a higher proportion of long-term health products in the GWP in Q1.
Now turning to our cost items. Cost of revenue for Q1 decreased by 4% year-over-year to RMB 147.8 million, primarily due to a slowdown in client acquisition activity during the month of February and March, which resulted in decreased personnel costs paid to our insurance consultants and decreased service fees paid to our user traffic channel partners. As a percentage of total revenues, total cost of revenues declined to 59.4% in the quarter from 61.4% in the same period last year.
Selling expenses for the quarter increased by 83.1% year-over-year to RMB 53 million, which was primarily attributable to the increase in our sales and marketing headcount during the year of 2019 as well as increased advertising and marketing expenses in comparison to last year. However, selling expenses were down by 14.3% on a sequential basis as we rein in on our spending following the outbreak of COVID-19 in the first quarter. Our decision to scale back our advertising and marketing budget in Q1 was made in line with our belief that spending the money during the pandemic would likely deliver less optimal ROI during the quarter. And therefore, our resources will be better spent later as the economy and industry gradually recover in the second half of the year.
G&A expenses for the quarter increased by 112% year-over-year to RMB 39 million. This growth was primarily due to the increase in share-based compensation expenses, which grew to RMB 19.1 million in the quarter, and to a lesser extent, the increase in G&A headcount and professional fees. If we strip off the effect of SBC from the G&A number, G&A expenses only grew by 50.3% year-over-year and actually decreased by 17.1% on a sequential basis.
R&D expenses for the quarter grew by 74.4% year-over-year to RMB 11.2 million, primarily attributable to the increased headcount of R&D personnel during the year. On a sequential basis, R&D expenses will be essentially flat from last quarter.
During the first quarter, net loss was RMB 2.3 million, while non-GAAP net profit for the quarter was RMB 22.2 million, which represents our eighth consecutive profitable quarter on a non-GAAP basis.
It is very important to note our strong liquidity and healthy financial position, which we believe is of paramount importance in the context of the current challenging macro environment. As of the end of the quarter, we had a combined cash and cash equivalents balance of RMB 500.2 million or roughly USD 17 million. Going forward, this robust liquidity position will enable us to weather the current headwinds and, more importantly, capitalize on those growth opportunities, which we believe will emerge as we come out of the bottom in the second half of this year.
With regards to our Q2 outlook, Mr. Ma already shared some run rate numbers in April. I would like to add some additional color here. In April, our platform facilitated approximately RMB [ 240 ] million compared to RMB 598 million for the entire Q1. More notably, of that RMB [ 240 ] million, first year premiums accounted for approximately 60% or RMB 150 million in comparison to RMB 277 million for the whole Q1. We are quite encouraged by these run rate numbers for April as they do point to positive signs of recovery. However, we do remain cautiously optimistic about the rest of the quarter. And provided that we do not experience a second wave outbreak in China, coming to our formal guidance for the next quarter, Q2, we currently expect total operating revenue to be in the range of RMB 210 million to RMB 230 million.
This forecast reflects the company's current and preliminary views on the market and operational conditions, which are subject to change caused by various uncertainties, including those related to the ongoing COVID-19 pandemic.
With that, that concludes our prepared remarks for today, and I'd like to turn the call to Q&A for now. Thank you.